Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Cancer cell or component thereof
Patent
1993-11-01
1996-01-16
Lacey, David L.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Cancer cell or component thereof
424 931, 424 937, 4241381, A61K 3900, A61K 39395
Patent
active
054845963
ABSTRACT:
This invention relates to a method of cancer therapy for treating human patients with resectable solid tumors to inhibit recurrence and formation of metastases, comprising surgically removing tumor tissue from a human cancer patient, treating the tumor tissue to obtain tumor cells, irradiating the tumor cells to be viable but non-tumorigenic, preparing a vaccine comprising about 10.sup.7 viable but non-tumorigenic tumor cells per dose and injecting the vaccine intradermally into the human patient after the patient's immune system has recovered from surgery.
REFERENCES:
patent: 4172124 (1979-10-01), Koprowski et al.
patent: 4196265 (1980-04-01), Koprowski et al.
patent: 4340586 (1982-07-01), Bekierkunst et al.
patent: 4471057 (1984-09-01), Koprowski et al.
patent: 4522918 (1985-06-01), Schlom
patent: 4612282 (1986-09-01), Schlom et al.
patent: 4613576 (1986-09-01), Cote et al.
patent: 4618577 (1986-10-01), Handley et al.
patent: 4661586 (1987-04-01), Levy et al.
patent: 4828991 (1989-05-01), Hanna et al.
patent: 4997762 (1991-03-01), Hanna et al.
patent: 5106738 (1992-04-01), Hanna et al.
patent: 5180814 (1993-01-01), Hanna et al.
Hoover, H. C., Jr. et al., J. Clin Oncology, 11(3):390-399, Mar. 1993.
Chatal, J-F. et al., J. Nucl. Med., 25(3);307-314, 1984.
Cote, R. J. et al., PNAS, 80:2026-2030, Apr. 1983.
Kozbor, D. et al., PNAS., 79:6651-6655, Nov. 1982.
Kammerman, S. et al., Cancer Res., 37:2578-2582, 1977.
Chatterjee, M. B. et al, Cancer Immunol Immunother, 38:75-82, 1994.
Moldofsky, P. J. et al., Radiology, 149:549-555, 1983.
Mach, J-P. et al., Cancer Res., 43:5593-5600, Nov. 1983.
Sparlos, F. et al, Neoplasm Immunity: Solid Tumor Therapy ed. Crispon, Ray G., pp. 179-188, 1977.
Hanna, M. G. et al., Cancer Research, 41:4001-4009, Oct. 1981.
Tarin, David et al, Invasion Metastasis, 4:198-208, 1984.
Hofer, K. G. et al., Europ. J. Cancer, 10:49-56, 1974.
Jean L. Marx, "Monoclonal Antibodies in Cancer," Science, vol. 216 (1982), pp. 283-285.
R. K. Oldman and R. V. Smalley, "Immunotherapy: The Old and the New," J. Biol. Response Modifiers, vol. 2 (1983), pp. 1-37.
R. Levy et al., Annual Review of Medicine, vol. 34, pp. 107-116 (1983).
M. Herlyn et al., Proc. Natl. Acad. Sci., USA, vol. 76(3), pp. 1438-1442 (Mar., 1979).
M. Herlyn et al., J. Clinical Immunology, vol. 2(2), pp. 135-140 (1982).
Paul T. Stratte et al., "In Vivo Effects of Murine Monoclonal Anti-Human T Cell Antibodies in Subhuman Primates," J. Biol. Response Modifiers, vol. 1 (1982), pp. 137-148.
H. C. Hoover, Jr. et al., "Delayed Cutaneous Hypersensitivity to Autologous Tumor Cells in Colorectal Cancer Patients Immunized with an Autologous Tumor Cell: Bacillus Calmette-Guerin Vaccine," Cancer Research, vol. 44 (Apr. 1984), pp. 1671-1676.
L. C. Peters et al., "Preparation of Immunotherapeutic Autologous Tumor Cell Vaccines from Solid Tumors," Cancer Research, vol. 39 (Apr. 1979), pp. 1353-1360.
L. Lindholm et al., "Monoclonal Antibodies against Gastrointestinal Tumour-Associated Antigens Isolated as Monosialogangliosides," Int. Arch. Allergy Appl. Immuno., vol. 71 (1983), pp. 178-181.
H. Koprowski et al., Somat. Cell Genet., vol. 5 (1979), pp. 957-972.
L. Ollson and H. S. Kaplan, "Human-human Hybridomas Producing Monoclonal Antibodies of Predefined Antigenic Specificity," Proc. Natl. Acad. Sci., vol. 77, pp. 5429-5431.
J. L. Butler et al., "Delineation of Optimal Conditions for Producing Mouse-Human Heterohybridomas from Human Peripheral Blood B Cells of Immunized Subjects," J. Immunology, vol. 130, No. 1, pp. 165-168.
Frederick Cancer Research Center Annual Report, 1980, "Immunotherapy," pp. 64-65.
Monoclonal Antibodies and Cancer, B. D. Boss et al., Eds., Academic Press, Orlando (1983), pp. 135-142, N. N. H. Teng et al.
Monoclonal Antibodies and Cancer, B. D. Boss et al., Eds., Academic Press, Orlando (1983), pp. 143-155, K. A. Foon et al.
Monoclonal Antibodies and Cancer, B. D. Boss et al., Eds., Academic Press, Orlando (1983), pp. 163-170, M. C. Glassy et al.
Monoclonal Antibodies and Cancer, B. D. Boss et al., Eds., Academic Press, Orlando (1983), pp. 171-180, K. Sikora et al.
J. E. Boyd et al., Trends in Biotechnology, vol. 2, No. 3, pp. 70-77, (1984).
D. L. Toffaletti et al., J. of Immunology, vol. 130, No. 6, pp. 2982-2986 (1983).
R. W. O'Donnell et al., Som. Cell Mol. Gen., vol. 10, No. 2, pp. 195-204 (1984).
Haspel et al., Cancer Research;, vol. 45, pp. 3951-3961 (Aug. 1985).
Finan et al., Br. J. Cancer, vol. 46, No. 1, Abstract (1982).
Sikora et al., Br. J. Cancer, vol. 43, No. 5, pp. 696-700.
M. Herlyn et al., Int. J. Cancer, vol. 27, pp. 769-774 (1981).
Z. Steplewski et al., Cancer Research, vol. 41, pp. 2723-2727 (Jul., 1981).
Stedman's Medical Dictionary, 24th Ed., Williams & Wilkins, Baltimore, Md., (1982), p. 144.
Kohler et al., Nature, vol. 256, pp. 495-498 (Aug. 1975).
Liao et al., Cancer Research, vol. 38, No. 12, pp. 4395-4400 (1978).
Sikora et al., Nature, vol. 300, pp. 316-317.
Wunderlich et al., Eur. J. Cancer Clin. Oncol., vol. 17, No. 7, pp. 719-730.
J. Schlom et al., Prac. Natl. Acad. Sci., USA, vol. 77, No. 11, pp. 6841-6845, (Nov., 1980).
Monoclonal Antibodies and Cancer, B. D. Boss et al., Eds., Academic Press, Orlando (1983), pp. 181-184, P. A. W. Edwards et al.
T. Takayama, Nihon. Univ. J. Med., vol. 26, No. 5, Abstract, (1984).
Handbook of Monoclonal Antibodies, A. Ferrone et al., Eds. Noyes Pub. (1985), pp. 304-346.
Monoclonal Antibodies in Clinical Medicine, A. J. McMichael et al., Ed., Academic Press, London (1982), pp. 111-128, E. S. Lennox et al.
Monoclonal Antibodies in Clinical Medicine, A. J. McMichael et al., Ed., Academic Press, London (1982), pp . 17-35, Kaplan et al.
B. Fermor et al., "Proliferative and Metastatic Potential of Exfoliated Colorectal Cancer Cells," JNCI, vol. 76, No. 2, Feb. 1986, pp. 347-349.
M. G. Hanna et al., "Active Specific Immunotherapy of Established Micrometastases with BCG Plus Tumor Cell Vaccines," Cancer, 49:659-664 (1982).
C. McCune et al., "Active Specific Immunotherapy with Tumor Cells and Corynebacterium Parvum," Cancer, 43:1619-1623, (1979).
M. Ashley et al., "Systemic Specific Immunotherapy of Guinea Pig Lymph Mode Metastases with Vaccines of Lice or Irradiated Tumor Cells Plus BCG Cell Walls," Federation Proceedings, vol. 39, No. 3, Abs. 1099, Mar. 1, 1980.
E. Yarkoni et al., "Influence of Type of Oil and Surfactant Concentration on the Efficacy of Emulsified Mycobacterium bovis BCG Cell Walls to Induce Tumor Regression in Guinea Pigs," Infection and Immunity, vol. 28, No. 3, pp. 881-886, Jun. 1980.
P. Minden, "Suppression and Immunotherapy of the Guinea Pig Line 10 Hepatocarcinoma Mediated by Heat-killed Disrupted Mycobacterium bovis Strain Bacillus Calmette-Guerin," Cancer Research, vol. 40, pp. 3214-3217 Sep. 1980.
G. Aranha et al., "Adjuvant Immunotherapy of Malignant Melanoma," Cancer 43:1297-1303, 1979.
M. G. Hanna et al., "Immunotherapy of Established Micrometastase with Bacillus Calmette-Guerin Tumor Cell Vaccine," Cancer Research, vol. 38 pp. 204-209, Jan. 1978.
Sevier et al., Clin. Chem., 27/11, pp. 1797-1806 (1981).
Hanna, Jr. Michael G.
Hoover, Jr. Herbert C.
Peters Leona C.
Akzo N.V.
Blackstone William M.
Lacey David L.
Loring Susan A.
LandOfFree
Active specific immunotherapy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Active specific immunotherapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Active specific immunotherapy will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-307883